Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis

ANTONIO RIVERO ROMÁN2026-01-292026-01-29201810.1093/jac/dky2342-s2.0-85053816268https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/29590Infectious DiseasesMicrobiology (medical)PharmacologyPharmacology (medical)Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosisresearch article